Question

A 54-year-old with new HFrEF (EF 35%) without diabetes asks about SGLT2 inhibitors. What do guidelines recommend?

Accepted Answer

SGLT2 inhibitors reduce HF hospitalizations and CV death regardless of diabetes status

Answer

SGLT2 inhibitors only if diabetes present

Answer

Avoid SGLT2 inhibitors if EF <40%

Answer

Use SGLT2 inhibitors only after ARNI, beta blocker, and MRA maximized

Answer

SGLT2 inhibitors are diuretics only

Practice question

A 54-year-old with new HFrEF (EF 35%) without diabetes asks about SGLT2 inhibitors. What do guidelines recommend?